Navigation Links
Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
Date:9/16/2008

Company appoints Dr. William Haseltine, PhD to its Board of Directors

BALTIMORE, Sept. 16 /PRNewswire/ -- Profectus BioSciences Inc., a biotechnology company that develops therapeutic and preventative technologies to reduce the morbidity and mortality of viral diseases, today announced the appointment of Dr. William Haseltine, PhD, to the company's board of directors. A seasoned expert in innovating life saving drugs and medical devices, Haseltine brings more than thirty years of expertise in science and business development.

Dr. Haseltine currently serves as president of the Haseltine Foundation for Medical Sciences and the Arts, a foundation that supports access to high quality health for the poor and middle class of developing countries. He is also the chairman of Haseltine Global Health, LLC, a company dedicated to developing life saving drugs and medical devices.

In addition to these positions, he serves as an advisor to CMEA, a venture capital company, the Reliance Innovation Council, India and to several other biotechnology and pharmaceutical companies. Collectively, Dr. Haseltine has founded nine successful biotechnology companies including Human Genome Sciences, Inc.

"Dr. Haseltine is one of the industry's most respected and talented individuals. His addition to our company is a tremendous testament to the things we are looking to accomplish as we proceed with the commercialization phase of our operations, and becoming the leading viral disease company," said Shawn Patrick O'Brien, president and CEO of Profectus BioSciences. "Dr. Haseltine will provide strategic insight in helping us enhance and expand our technologies."

Dr. Haseltine also has contributed to the academic community and is well known for his pioneering research on cancer, HIV/AIDS and genomics. As a professor at Harvard Medical School, he was founder and the chair of two academic research departments. Today, he is an adjunct professor at The Scripps Institute for Medical Research and the Institute of Chemical Engineering the University of Mumbai, India. He is chairman of the Board of the Berkeley Center for Synthetic Biology. Dr. Haseltine has published more than 200 manuscripts in peer reviewed journals and is the author of several books.

"This is a very exciting time for Profectus BioSciences," said Dr. Haseltine. "With its seasoned leadership and innovative technologies, the company is perfectly positioned to help improve those who are afflicted with viral diseases. I'm very enthused to be a part of an organization that has the resources and expertise to realize this incredible opportunity."

Aside from his professional expertise, Dr. Haseltine is also very active in public service. He is co-chair of the President's Council of the Cold Spring Harbor Laboratory, a member of the Advisory Board of the Global Coalition on HIV/AIDS and he is a governor of the New York Academy of Science. He is a member of the Executive Committee of the Brookings Institution, a member of the Council on Foreign Relations, and a member of the Chairman's Circle of the Asia Society. He is also a founder of the American Freedom Campaign.

About Profectus BioSciences Inc.

Profectus BioSciences Inc. began operations in early 2005 to develop and commercialize technologies to reduce the morbidity and mortality caused by human viral diseases, including the human immunodeficiency virus (HIV), the causative agent of AIDS. Founded to fulfill the mission of its co-founders Drs. Gallo, Blattner, and Redfield (collectively, the founders) for "bench-top-to-bedside" medicine, the Company applies its specific scientific expertise to help commercialize promising unique technologies used for human and animal health. For more information please visit: http://www.profectusbiosciences.com.


'/>"/>
SOURCE Profectus BioSciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
2. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
3. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
4. Protect Marylands Bioscience Industry
5. Progenitor Cell Therapy Secures Industry Accreditation
6. Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
7. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
8. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
11. Nile Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):